TW200610522A - Substituted ethane-1,2-diamines for the treatment of alzheimer's disease - Google Patents
Substituted ethane-1,2-diamines for the treatment of alzheimer's diseaseInfo
- Publication number
- TW200610522A TW200610522A TW094116516A TW94116516A TW200610522A TW 200610522 A TW200610522 A TW 200610522A TW 094116516 A TW094116516 A TW 094116516A TW 94116516 A TW94116516 A TW 94116516A TW 200610522 A TW200610522 A TW 200610522A
- Authority
- TW
- Taiwan
- Prior art keywords
- disease
- alzheimer
- diamines
- treatment
- substituted ethane
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04012182 | 2004-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200610522A true TW200610522A (en) | 2006-04-01 |
Family
ID=34925098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094116516A TW200610522A (en) | 2004-05-22 | 2005-05-20 | Substituted ethane-1,2-diamines for the treatment of alzheimer's disease |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20060025345A1 (zh) |
| AR (1) | AR049282A1 (zh) |
| TW (1) | TW200610522A (zh) |
| WO (1) | WO2005113582A1 (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| WO2006103038A1 (en) * | 2005-03-30 | 2006-10-05 | Boehringer Ingelheim International Gmbh | Substituted 1,2-ethylendiamines, medicaments comprising said compound; their use and their method of manufacture |
| EP1913017A1 (en) * | 2005-08-03 | 2008-04-23 | Boehringer Ingelheim International GmbH | Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |
| EP1915352A1 (de) * | 2005-08-11 | 2008-04-30 | Boehringer Ingelheim International GmbH | Verbindungen zur behandlung der alzheimer erkrankung |
| JP2009504614A (ja) * | 2005-08-11 | 2009-02-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アルツハイマー病の治療用化合物 |
| US20100298278A1 (en) * | 2005-08-11 | 2010-11-25 | Christian Eickmeier | Inhibitors of beta-secretase for the treatment of alzheimer's disease |
| US9169203B2 (en) * | 2012-01-06 | 2015-10-27 | Novus International, Inc. | Sulfoxide-based surfactants |
| US10584306B2 (en) | 2017-08-11 | 2020-03-10 | Board Of Regents Of The University Of Oklahoma | Surfactant microemulsions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO812612L (no) * | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| AU573735B2 (en) * | 1983-02-07 | 1988-06-23 | Aktiebolaget Hassle | Peptide analogue enzyme inhibitors |
| EP0144290A3 (de) * | 1983-12-01 | 1987-05-27 | Ciba-Geigy Ag | Substituierte Aethylendiaminderivate |
| BR0306724A (pt) * | 2002-01-04 | 2006-04-11 | Elan Pharm Inc | carboxamidas amino substituìdas para tratamento de doença de alzheimer |
| US20050090449A1 (en) * | 2003-05-13 | 2005-04-28 | Boehringer Ingelheim International Gmbh | Novel statine derivatives for the treatment of Alzheimer's disease |
-
2005
- 2005-05-14 WO PCT/EP2005/005299 patent/WO2005113582A1/en not_active Ceased
- 2005-05-20 TW TW094116516A patent/TW200610522A/zh unknown
- 2005-05-20 AR ARP050102082A patent/AR049282A1/es unknown
- 2005-05-20 US US11/133,948 patent/US20060025345A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005113582A1 (en) | 2005-12-01 |
| US20060025345A1 (en) | 2006-02-02 |
| AR049282A1 (es) | 2006-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200738242A (en) | Dihydropteridinones in the treatment of respiratory diseases | |
| MY135841A (en) | Novel benzodioxoles | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| GB0318447D0 (en) | Therapeutic agents | |
| TW200500358A (en) | Compounds | |
| ATE502633T1 (de) | Cyclosporins zur behandlung und vorbeugung von augenerkrankungen | |
| NO20070606L (no) | Inhibitorer av IAP | |
| IL183514A0 (en) | Pyrrolidine inhibitors of iap | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| ATE547417T1 (de) | Dihydropyrimidinverbindungen und ihre verwendungen bei der herstellung von medikamenten zur behandlung und prävention antiviraler krankheiten | |
| UA85707C2 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| TW200510427A (en) | Novel fused heterocycles and uses thereof | |
| TW200630374A (en) | Thiazolyldihydroindazoles | |
| IL205045A (en) | Piperidinyl and piperazine derivatives, preparations containing them and their uses | |
| PL1809288T3 (pl) | Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| TW200610522A (en) | Substituted ethane-1,2-diamines for the treatment of alzheimer's disease | |
| DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| TW200740781A (en) | Novel compounds | |
| WO2006050861A3 (en) | Statine derivatives for the treatment of alzheimer's disease | |
| TW200634013A (en) | Quinoline derivative, its use, production and pharmaceutical agents containing the derivative |